Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 31.
A
Artim-Esen, B;
Pericleous, C;
Mackie, I;
Ripoll, VM;
Latchman, D;
Isenberg, D;
Rahman, A;
... Giles, I; + view all
(2015)
Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays.
Arthritis Research & Therapy
, 17
, Article 47. 10.1186/s13075-015-0568-7.
|
 |
B
|
Badar, A;
Kiru, L;
Kalber, TL;
Jathoul, A;
Straathof, K;
Årstad, E;
Lythgoe, MF;
(2015)
Fluorescence-guided development of a tricistronic vector encoding bimodal optical and nuclear genetic reporters for in vivo cellular imaging.
EJNMMI Res
, 5
, Article 18. 10.1186/s13550-015-0097-z.
|
|
Beavan, M;
McNeill, A;
Proukakis, C;
Hughes, DA;
Mehta, A;
Schapira, AH;
(2015)
Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.
JAMA Neurol
, 72
(2)
201 - 208.
10.1001/jamaneurol.2014.2950.
|
 |
C
|
Cohen, H;
Doré, CJ;
Clawson, S;
Hunt, BJ;
Isenberg, D;
Khamashta, M;
Muirhead, N;
(2015)
Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Lupus
, 24
(10)
pp. 1087-1094.
10.1177/0961203315581207.
|
|
|
Cohen, H;
Hunt, B;
Efythymiou, M;
Arachchillage, D;
Ruiz, M;
Clawson, S;
Muirhead, N;
... Collaborators, RAPST; + view all
(2015)
Raps (rivaroxaban in antiphospholipid syndrome): a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Journal of Thrombosis and Haemostasis
, 13
, Article LB003. DOI: 10.1111/jth.12993.
|
D
|
Dabrowska, A;
Venero, JL;
Iwasawa, R;
Hankir, MK;
Rahman, S;
Boobis, A;
Hajji, N;
(2015)
PGC-1α controls mitochondrial biogenesis and dynamics in lead-induced neurotoxicity.
Aging (Albany NY)
, 7
(9)
pp. 629-647.
10.18632/aging.100790.
|
|
|
Dickson, GJ;
Bustraan, S;
Hills, RK;
Ali, A;
Goldstone, AH;
Burnett, AK;
Linch, DC;
(2015)
The value of molecular stratification for CEBPA_DM and NPM1_MUT_FLT3_WT genotypes in older patients with acute myeloid leukaemia.
British Journal of Haematology
10.1111/bjh.13873.
|
 |
G
|
Gale, RE;
Tawana, K;
Wang, J;
Renneville, A;
Bodor, C;
Hills, R;
Loveday, C;
... Fitzgibbon, J; + view all
(2015)
Disease evolution and outcomes in familial AML with germline CEBPA mutations.
Blood
, 126
(10)
pp. 1214-1223.
10.1182/blood-2015-05-647172.
|
|
Gale, RE;
Lamb, K;
Allen, C;
El-Sharkawi, D;
Stowe, C;
Jenkinson, S;
Tinsley, S;
... Linch, DC; + view all
(2015)
Simpson's Paradox and the Impact of Different DNMT3A Mutations on Outcome in Younger Adults With Acute Myeloid Leukemia.
Journal of Clinical Oncology
, 33
(18)
pp. 2072-2083.
10.1200/JCO.2014.59.2022.
|
|
|
Ghorashian, S;
Veliça, P;
Chua, I;
McNicol, AM;
Carpenter, B;
Holler, A;
Nicholson, E;
... Stauss, HJ; + view all
(2015)
CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor.
Journal of Immunology
, 194
(3)
1080 - 1089.
10.4049/jimmunol.1401703.
|
|
|
Gonzalez Malagon, SG;
Melidoni, AN;
Hernandez, D;
Omar, BA;
Houseman, L;
Veeravalli, S;
Scott, F;
... Shephard, EA; + view all
(2015)
The phenotype of a knockout mouse identifies flavin-containing monooxygenase 5 (FMO5) as a regulator of metabolic ageing.
Biochemical Pharmacology
, 96
(3)
pp. 267-277.
10.1016/j.bcp.2015.05.013.
|
H
|
Hamilton, NJ;
Kanani, M;
Roebuck, DJ;
Hewitt, RJ;
Cetto, R;
Culme-Seymour, EJ;
Toll, E;
... Birchall, MA; + view all
(2015)
Tissue-engineered tracheal replacement in a child: a 4-year follow-up study.
Am J Transplant
, 15
(10)
pp. 2750-2757.
10.1111/ajt.13318.
|
|
J
|
Jenkinson, S;
Kirkwood, AA;
Goulden, N;
Vora, A;
Linch, DC;
Gale, RE;
(2015)
Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.
Leukemia
10.1038/leu.2015.206.
(In press).
|
|
K
|
Kottaridis, PD;
North, J;
Tsirogianni, M;
Marden, C;
Samuel, ER;
Jide-Banwo, S;
Grace, S;
(2015)
Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial.
PLoS One
, 10
(6)
, Article e0123416. 10.1371/journal.pone.0123416.
|
|
|
Koumoutsea, EV;
Garbowski, M;
Porter, J;
(2015)
Synergistic intracellular iron chelation combinations: mechanisms and conditions for optimizing iron mobilization.
British Journal of Haematology
, 170
(6)
pp. 874-883.
10.1111/bjh.13512.
|
|
L
|
Löhle, M;
Hughes, D;
Milligan, A;
Richfield, L;
Reichmann, H;
Mehta, A;
Schapira, AH;
(2015)
Clinical prodromes of neurodegeneration in Anderson-Fabry disease.
Neurology
, 84
(14)
1454 - 1464.
10.1212/WNL.0000000000001450.
|
P
|
Paul, DS;
Jones, A;
Sellar, RS;
Mayor, NP;
Feber, A;
Webster, AP;
Afonso, N;
... Beck, S; + view all
(2015)
A donor-specific epigenetic classifier for acute graft-versus-host disease severity in hematopoietic stem cell transplantation.
Genome Medicine
, 7
(1)
, Article 128. 10.1186/s13073-015-0246-z.
|
|
|
Philip, BM;
(2015)
RQR8: A universal safety switch for cellular therapies.
Doctoral thesis , UCL (University College London).
|
|
Phillips, EH;
Westwood, JP;
Brocklebank, V;
Wong, EKS;
Tellez, JO;
Marchbank, KJ;
Mcguckin, S;
... Scully, MA; + view all
(2015)
The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
Journal of Thrombosis and Haemostasis
, 14
(1)
pp. 175-185.
10.1111/jth.13189.
|
|
R
|
Rahman, S;
Housein, Z;
Dabrowska, A;
Mayán, MD;
Boobis, AR;
Hajji, N;
(2015)
E2F1-mediated FOS induction in arsenic trioxide-induced cellular transformation: effects of global H3K9 hypoacetylation and promoter-specific hyperacetylation in vitro.
Environ Health Perspect
, 123
(5)
pp. 484-492.
10.1289/ehp.1408302.
|
|
S
|
Smith, L;
McCourt, O;
Heinrich, M;
Paton, B;
Yong, K;
Wardle, J;
Fisher, A;
(2015)
Multiple myeloma and physical activity: a scoping review.
BMJ Open
, 5
, Article e009576. 10.1136/bmjopen-2015-009576.
|
|
Smith, NMG;
Mlcochova, P;
Watters, SA;
Aasa-Chapman, MMI;
Rabin, N;
Moore, S;
Edwards, SG;
... Gupta, RK; + view all
(2015)
Proof of principle for immune control of 1 global HIV1 reactivation in vivo.
Clinical Infectious Diseases
10.1093/cid/civ219.
|
 |
|
Stowe, C;
Pizzey, A;
Kalber, T;
Badar, A;
Lythgoe, M;
Pule, M;
(2015)
Flow-Based Single Cell Deposition for High-Throughput Screening of Protein Libraries.
PLoS One
, 10
(11)
, Article e0140730. 10.1371/journal.pone.0140730.
|
|
T
|
Tinsley, S;
Meja, K;
Shepherd, C;
Khwaja, A;
(2015)
Synergistic induction of cell death in haematological malignancies by combined phosphoinositide-3-kinase and BET bromodomain inhibition.
British Journal of Haematology
, 170
(2)
pp. 275-278.
10.1111/bjh.13283.
|
|
U
|
Underwood, MI;
(2015)
The relationship between ADAMTS13 genotype and phenotype in congenital thrombotic thrombocytopenic purpura and characterisation of ADAMTS13 mutants.
Doctoral thesis , UCL (University College London).
|
|
V
|
Valle, JW;
Wasan, H;
Lopes, A;
Backen, AC;
Palmer, DH;
Morris, K;
Duggan, M;
... Bridgewater, JA; + view all
(2015)
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.
Lancet Oncology
, 16
(8)
pp. 967-978.
10.1016/S1470-2045(15)00139-4.
|
W
|
Waters, AM;
Asfahani, R;
Carroll, P;
Bicknell, L;
Lescai, F;
Bright, A;
Chanudet, E;
... Beales, PL; + view all
(2015)
The kinetochore protein, CENPF, is mutated in human ciliopathy and microcephaly phenotypes.
J Med Genet
, 52
(3)
147 - 156.
10.1136/jmedgenet-2014-102691.
|
|
|
Westwood, J-P;
(2015)
The Role of Complement Anaphylatoxins in Systemic Disease.
Doctoral thesis , UCL (University College London).
|
|
Wilson, D;
Charidimou, A;
Shakeshaft, C;
Ambler, G;
White, M;
Cohen, H;
Yousry, T;
... Werring, DJ; + view all
(2015)
Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type.
Neurology
, 86
(4)
pp. 360-366.
10.1212/WNL.0000000000002310.
|
|
Y
|
Yang, JHM;
Cutler, AJ;
Ferreira, RC;
Reading, JL;
Cooper, NJ;
Wallace, C;
Clarke, P;
... Tree, TIM; + view all
(2015)
Natural Variation in Interleukin-2 Sensitivity Influences Regulatory T-Cell Frequency and Function in Individuals With Long-standing Type 1 Diabetes.
Diabetes
, 64
(11)
pp. 3891-3902.
10.2337/db15-0516.
|
|
Z
|
Zelenay, S;
van der Veen, AG;
Boettcher, JP;
Snelgrove, KJ;
Rogers, N;
Acton, SE;
Chakravarty, P;
... Reis e Sousa, C; + view all
(2015)
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity.
Cell
, 162
(6)
pp. 1257-1270.
10.1016/j.cell.2015.08.015.
|
